iSpot estimates via published trade reports · two fractions, labeled · a network’s share of pharma dollars is not pharma’s share of that network
Advertisement
WHO TAKES THE DRUG DOLLARS
January through August 2025. This is each network’s share of pharmaceutical TV spending, not the share of that network’s own ads that are pills.
| Network | Share of pharma TV dollars |
|---|---|
| ABC | 16.91% |
| CBS | 15.46% |
| NBC | 14.73% |
| FOX | 5.15% |
| ESPN | 2.44% |
| Fox News | 1.92% |
| TBS | 1.91% |
| HGTV | 1.85% |
| Food Network | 1.79% |
| TNT | 1.64% |
| All other | 45.31% |
Pharma spent $3.73 billion on TV ads in those eight months, 14 percent of all TV ad spending. ABC, CBS, and NBC took close to half the drug dollars. Source: industry tally reported by StudyFinds, Sept 2025.
JUNE 2026, BY IMPRESSIONS
A different cut. Share of pharma impressions that month, not dollars, and not the 2025 table above.
| Network | Pharma impression share |
|---|---|
| CBS | 11.51% |
| ABC | 9.95% |
| Fox News | 9.65% |
| NBC | 7.27% |
| MS NOW | 4.66% |
iSpot via MM+M, June 2026. Top linear program that month: ABC World News Tonight with David Muir, 2.37 percent of pharma impressions. CBS was the biggest network destination.
2025, TOP DRUGS ON TV
Estimated national TV spend. Immunology and the weight-loss shots are the buy. Top 10 brands combined: $2.67 billion.
| Drug | Company | Condition | Spend |
|---|---|---|---|
| Skyrizi | AbbVie | Psoriasis, Crohn’s, colitis | $439.6 million |
| Tremfya | Johnson & Johnson | Psoriasis, Crohn’s, colitis | $431 million |
| Rinvoq | AbbVie | Eczema, colitis, arthritis | $376.4 million |
| Wegovy | Novo Nordisk | Obesity | $298.1 million |
| Dupixent | Sanofi / Regeneron | Eczema, asthma | $241.3 million |
| Rexulti | Lundbeck / Otsuka | Depression, Alzheimer’s | $241.1 million |
| Caplyta | Johnson & Johnson | Depression, bipolar | $185.7 million |
| Jardiance | Lilly / Boehringer | Diabetes, kidney disease | $171.5 million |
| Zepbound | Eli Lilly | Obesity | $160.1 million |
| Vraylar | AbbVie | Bipolar, depression | $128.9 million |
iSpot national TV estimates via Fierce Pharma, full-year 2025, published Jan 16, 2026. AbbVie owns three of the ten.
Advertisement
Evening news is the shelf
In 2024, prescription brands put 22.3 percent of national linear spend into news and information, and 17.6 percent into sports. ABC, CBS, Fox, ESPN, and NBC combined took 52.8 percent of those dollars.
The broadcast evening newscasts are where a large share of that news buy lands. Fox News took 1.92 percent of the 2025 drug dollars in the eight-month tally. The impression cut in June 2026 is higher. Both numbers stay on the page. They are not the same meter.
THE BUY IS MOVING
Prescription ads on TV and streaming, 2026.
| Quarter | Spend | Streaming share |
|---|---|---|
| Q1 2026 | $2.52 billion | 32% |
| Q2 2026 | $2.04 billion | — |
| Q3 2026 | $1.99 billion | 42% |
iSpot via eMarketer, Oct 9, 2026. Streaming’s share of prescription TV dollars rose from 32 percent in the first quarter to 42 percent in the third. Linear is still the evening-news story. The same companies are moving part of the buy.
2024 baseline: prescription brands spent $5.15 billion on national linear TV, 11.6 percent of ad dollars on national broadcast and cable. Guideline / MediaRadar transparency report.
Advertisement